Cerity Partners LLC Novo Nordisk A S Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cerity Partners LLC holds 790,636 shares of NVO stock, worth $67.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

790,636

Previous 608,703 29.89%

Holding current value

$67.2 Million

Previous $86.9 Million 8.35%

% of portfolio

0.21%

Previous 0.23%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $21.7 Million - $26.5 Million	181,933 Added 29.89%	790,636 $94.1 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $5.47 Million - $6.55 Million	-44,616 Reduced 6.83%	608,703 $86.9 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $28.2 Million - $37.6 Million	276,287 Added 73.28%	653,319 $83.9 Million
Q4 2023 Jan 26, 2024	BUY	$87.78 - $105.45 $13.9 Million - $16.6 Million	157,788 Added 71.97%	377,032 $39 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $12 Million - $26.3 Million	131,740 Added 150.55%	219,244 $19.9 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $918,722 - $1.02 Million	5,890 Added 7.22%	87,504 $14.2 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $473,909 - $569,880	3,581 Added 4.59%	81,614 $13 Million
Q4 2022 Feb 15, 2023	BUY	$102.55 - $135.33 $3.9 Million - $5.15 Million	38,036 Added 95.1%	78,033 $10.6 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $282,505 - $346,697	-2,965 Reduced 6.9%	39,997 $3.99 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $1.95 Million - $2.3 Million	18,874 Added 78.35%	42,962 $4.79 Million
Q1 2022 Apr 25, 2022	SELL	$93.1 - $112.54 $1.28 Million - $1.54 Million	-13,722 Reduced 36.29%	24,088 $2.47 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $3.29 Million - $4.02 Million	34,322 Added 984.0%	37,810 $4.23 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $204,187 - $236,974	3,488 New	3,488 $228,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $571,146 - $667,368	-11,455 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$47.54 - $53.43 $544,570 - $612,040	11,455 New	11,455 $592,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $225,948 - $253,377	-4,829 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $223,872 - $254,150	4,829 New	4,829 $253,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $211,367 - $253,432	-4,359 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $207,183 - $234,209	4,359	4,359 $234,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Novo Nordisk A S Transaction History